Skip Navigation U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
Archive print banner

Work-Related Asthma

This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.

Please go to www.ahrq.gov for current information.

Full Title: Diagnosis and Management of Work-Related Asthma

October 2005

View or download Summary/Report


Structured Abstract

Objectives: To systematically review literature regarding the diagnosis and management of OA, and specifically, to compare specific inhalation challenge testing (SIC) with alternative tests, and to review management, including reduction or cessation of exposure.

Data Sources: Electronic databases and trials registries were searched. Additional references were identified by bibliographic searches of included studies, hand searches of conference proceedings, and contact with authors. Two researchers independently extracted data.

Review Methods:

  • Population: De-novo OA or a previous diagnosis of asthma that was exacerbated at work.
  • Study Design: Controlled clinical trials, prospective or retrospective cohort, cross-sectional, case-series.
  • Diagnosis: Intervention: At least two diagnostic tests, including one or more from a pre-determined hierarchy of 'reference standard' tests.
    Outcomes: 2 x 2 or 2 x 1 table, sensitivity, specificity, likelihood ratios, time to diagnosis, cost of diagnosis, and adverse effects.
  • Management: Intervention: Pharmacological treatment, removal, reduced, or continued exposure.
    Outcomes: Pulmonary function, medication use, quality of life, symptoms, economic consequences, and adverse events.

Results: One-hundred and twenty-four unique diagnostic studies and 65 unique management studies were included. Much of the evidence relates to sensitizer induced OA.

  • Diagnosis: Among the high molecular weight (HMW) asthmagens compared to SIC, non-specific bronchial provocation (NSBP) test, skin prick test (SPT), and serum specific IgE had sensitivities above 73 percent. The specificity was highest between serum specific IgE versus SIC (79.0 percent [95% CI: 50.5 to 93.3 percent]). The highest sensitivity among low molecular weight (LMW) asthmagens occurred between SPT and SIC (72.9 percent [95% CI: 59.7 to 83.0 percent]), but this applied only to LMW sensitizers for which SPT could be performed. When compared to SIC, serum specific IgE and SPT had similar specificities (88.9 percent [95% CI: 84.7 to 92.1 percent] and 86.2 percent [95% CI: 77.4 to 91.9 percent], respectively). For HMW asthmagens, a combined positive test result to NSBP test and SPT versus SIC yielded modest sensitivity (60.6 percent [95% CI: 21.0 to 89.9 percent]) yet high specificity (82.5 percent [95% CI: 54.0 to 95.0 percent]).
  • Management: Removed workers showed improved lung function and decreased non-specific bronchial responsiveness at followup; exposed workers were either no better or worse. Lack of data prevented conclusions about the effectiveness of reducing exposure. Removed workers suffered from reduced income and/or unemployment. Fully or partially exposed workers also appeared to have reduced earnings over time.

Conclusions:

  • Diagnosis: Single NSBP test, specific SPT, or serum specific IgE testing alone is insufficient to diagnose OA. While positive results would increase the likelihood of OA, a negative result would not exclude OA. The literature supports the concept of combined testing; however, additional research is required to determine which combination of tests would result in sufficient sensitivity and specificity that it could replace SIC.
  • Management: OA appears to be slow to resolve, and may worsen irrespective of subsequent exposure status. Patients who are removed from the workplace rarely experience complete resolution, may require medications, and experience continued airflow limitation. Standard treatments for asthma appear to be effective in OA; however, there is limited research.

Download Report

Diagnosis and Management of Work-Related Asthma

Evidence-based Practice Center: University of Alberta
Topic Nominator: American College of Chest Physicians (ACCP)

Current as of October 2005

 

The information on this page is archived and provided for reference purposes only.

 

AHRQ Advancing Excellence in Health Care